• RWD93 REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB-BEVACIZUMAB, LENVATINIB AND SORAFENIB IN THE PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD31 ASSESSING ADOPTION AND FEASIBILITY OF THE HONG KONG REFERENCE FRAMEWORK FOR PREVENTIVE CARE IN OLDER ADULTS: A CROSS-SECTIONAL SURVEY OF PRIMARY CARE PRACTITIONERS

    Oct 1, 2025, 00:00

  • RWD226 MULTIDIMENSIONAL BURDEN OF NEUROFIBROMATOSIS TYPE 1 (NF1): A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD71 ESTIMATING TREATMENT EFFECT ON SURVIVAL OUTCOMES FROM REAL WORLD DATA: INVERSE PROBABILITY OF TREATMENT WEIGHTING WITH MISSING DATA AND NON-PROPORTIONAL HAZARDS

    Oct 1, 2025, 00:00

  • RWD114 PHARMACOLOGICAL AND ELECTRONIC CIGARETTE INTERVENTIONS FOR SMOKING CESSATION IN PREGNANCY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD144 PREVALENCE AND HEALTHCARE RESOURCE UTILIZATION TREND IN LUNG CANCER, COLORECTAL CANCER, BREAST CANCER, AND PROSTATE CANCER IN JAPAN 2016–2024

    Oct 1, 2025, 00:00

  • RWD255 IMPORTANT FEATURES OF TELEREHABILITATION FOR MUSCULOSKELETAL PATIENTS: APPLYING AN IMPLEMENTATION SCIENCE FRAMEWORK TO INFORM THE SELECTION OF ATTRIBUTES FOR DISCRETE CHOICE EXPERIMENTS

    Oct 1, 2025, 00:00

  • RWD253 FORECASTING SURVIVAL IN NASOPHARYNGEAL CANCER PATIENTS WITH DIABETES THROUGH MACHINE LEARNING: A POPULATION-BASED ANALYSIS

    Oct 1, 2025, 00:00

  • RWD91 DIRECT MEDICAL COSTS OF NASOPHARYNGEAL CARCINOMA IN INDONESIA: A HEALTHCARE PAYER PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD92 STATIN USE AND THE PROGRESSION OF PARKINSON’S DISEASE: A POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD66 HEALTH-RELATED QUALITY OF LIFE AND ITS DETERMINANTS AMONG INDIVIDUALS WITH SPINAL CORD INJURY IN CHINA: EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD37 ADOPTING A CLOSED INTEGRATED PERIPHERAL INTRAVENOUS CANNULA SYSTEM IN AN AUSTRALIAN HOSPITAL: CLINICAL AND ECONOMIC IMPACT

    Oct 1, 2025, 00:00

  • RWD231 IMPACT OF CHILD MALTREATMENT ON THE COSTS OF HEALTH SERVICE USE AND PRODUCTIVITY LOSS: FINDINGS FROM THE AUSTRALIAN CHILD MALTREATMENT STUDY

    Oct 1, 2025, 00:00

  • RWD99 ASSESSING THE SOCIOECONOMIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY ON CARER’S LIFE IN AUSTRALIA: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD65 BALANCING INNOVATION AND AFFORDABILITY: HEALTH SYSTEM TRADE-OFFS IN THAILAND’S REIMBURSEMENT RESTRICTION POLICIES FOR HIGH-COST MEDICINES

    Oct 1, 2025, 00:00

  • RWD319 AN EMPIRICAL STUDY ON THE DISCOUNTING RATE OF PHARMACOECONOMIC EVALUATIONS IN CHINA

    Oct 1, 2025, 00:00

  • RWD312 CHANGING ETIOLOGY OF CIRRHOSIS AND OTHER CHRONIC LIVER DISEASES: IMPLICATIONS FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE IN NON-CIRRHOTIC PATIENTS

    Oct 1, 2025, 00:00

  • RWD227 DAILY DOSES AND DURATION OF GABAPENTIN AND PREGABALIN USE FOR PAIN MANAGEMENT AMONG OPIOID USERS BELOW AND ABOVE 65 YEARS OLD: TRENDS AND PATTERNS

    Oct 1, 2025, 00:00

  • RWD78 BURDEN OF INTRAVENOUS IMMUNOGLOBULIN USE AMONG ADULTS WITH GENERALIZED MYASTHENIA GRAVIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD321 COST-EFFECTIVENESS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN ELDERLY PATIENTS WITH SEVERE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Oct 1, 2025, 00:00

  • RWD288 REHABILITATION FOR PATIENTS WITH CANCER: SURVIVAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION BASED ON MULTICENTER CANCER REGISTRY AND ADMINISTRATIVE DATA IN JAPANESE REAL-WORLD SETTINGS

    Oct 1, 2025, 00:00

  • RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023

    Oct 1, 2025, 00:00

  • RWD202 EVALUATION OF THE APPLICATION OF CPR COMPOSITE ERROR ACTION RECOGNITION SYSTEM BASED ON ARTIFICIAL INTELLIGENCE TECHNOLOGY

    Oct 1, 2025, 00:00

  • RWD165 APPLYING REAL-WORLD EVIDENCE TO NATIONAL HEALTHCARE REIMBURSEMENT DECISION-MAKING: A STUDY ON ASSESSMENT FRAMEWORKS UNDER CHINA’S LECHENG PILOT POLICY

    Oct 1, 2025, 00:00

  • RWD5 UNLOCKING THE STRATEGIC POTENTIAL OF REAL-WORLD EVIDENCE IN THE ASIA – PACIFIC PHARMACEUTICAL MARKET: EXECUTIVE INSIGHTS AND COMMERCIAL IMPLICATIONS

    Oct 1, 2025, 00:00

  • RWD244 BODY WEIGHT-ASSOCIATED DIFFERENCES IN ADVERSE DRUG REACTION PROFILES OF AROMATASE INHIBITORS: A REAL-WORLD PHARMACOVIGILANCE STUDY USING FAERS DATABASE

    Oct 1, 2025, 00:00

  • RWD247 GEOGRAPHIC DISPARITIES IN ACCESS TO NATIONALLY NEGOTIATED ANTICANCER MEDICINES IN CHINA

    Oct 1, 2025, 00:00

  • RWD122 COST-EFFECTIVENESS ANALYSIS OF PRENATAL DIAGNOSTIC STRATEGIES AMONG KOREAN PREGNANT WOMEN

    Oct 1, 2025, 00:00

  • RWD63 METHOD OF AN EPIDEMIOLOGICAL RISK STUDY IN TENS OF THOUSANDS PATIENTS WITH WEARABLE CARDIOVERTER DEFIBRILLATOR FOR PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE PATIENTS WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION

    Oct 1, 2025, 00:00

  • RWD284 THE ASSOCIATION BETWEEN ANNUAL HOUSEHOLD INCOME AND TOTAL MONTHLY AMOUNT OF OUT-OF-POCKET MEDICAL EXPENSES PATIENTS ARE WILLING TO PAY AMONG PATIENTS OF INFERTILITY IN JAPAN: A CROSS-SECTIONAL PATIENT SURVEY

    Oct 1, 2025, 00:00

  • RWD239 ADVANCING COLORECTAL CANCER (CRC) RESEARCH IN JAPAN: INSIGHTS FROM ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATA IN JAPAN

    Oct 1, 2025, 00:00

  • Peer Reviewers

    Oct 1, 2025, 00:00

  • RWD298 PUBLIC HEALTH IMPACT ASSESSMENT OF RSVPREF3 OA ADJUVANTED VACCINE ON RESPIRATORY SYNCYTIA VIRUS IN TAIWAN, HONG KONG, AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD38 PRESCRIPTION PATTERN AND COSTS OF ANTIDIABETIC MEDICATIONS IN PATIENTS WITH TYPE 2 DIABETES BY SPECIALIST PHYSICIANS AND NON-SPECIALIST PHYSICIANS

    Oct 1, 2025, 00:00

  • RWD285 COST-UTILITY ANALYSIS OF ECULIZUMAB FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) IN THAILAND

    Oct 1, 2025, 00:00

  • RWD159 PREFERENCES AND WILLINGNESS TO PAY FOR MAINTENANCE INHALERS AMONG ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THAILAND: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD228 ASSOCIATION BETWEEN ANTICHOLINERGIC BURDEN AND THE RISK OF CARDIOVASCULAR EVENTS IN OLDER ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD205 COST-EFFECTIVENESS OF CONCURRENT KOREAN AND WESTERN MEDICINE TREATMENT VS. USUAL CARE FOR CAR ACCIDENT-RELATED WHIPLASH INJURIES IN KOREA: A MARKOV MODEL DECISION ANALYSIS

    Oct 1, 2025, 00:00

  • RWD186 A QUALITATIVE STUDY ON OBESE ADULTS’ PERCEPTIONS OF USING ARTIFICIAL INTELLIGENCE FOR WEIGHT MANAGEMENT COUNSELING

    Oct 1, 2025, 00:00

  • RWD161 COMPARISON OF RISK PREDICTION MODELS FOR KIDNEY DISEASE: AN EXTERNAL VALIDATION USING 0.5 MILLION UK BIOBANK PARTICIPANTS

    Oct 1, 2025, 00:00

  • RWD185 CAREGIVERS’ ACCEPTANCE AND PERSPECTIVES ON AN AUGMENTED REALITY-BASED PRESSURE ULCER ASSESSMENT DEVICE: A QUALITATIVE STUDY BASED ON THE TECHNOLOGY ACCEPTANCE MODEL

    Oct 1, 2025, 00:00

  • RWD184 FNEURONET: A SEX-SPECIFIC DEEP LEARNING FRAMEWORK FOR AUTISM SPECTRUM DISORDER (ASD) AND ATTENTION DEFICIT AND HYPERACTIVITY DISORDER (ADHD) CLASSIFICATION IN FEMALE COHORTS BASED ON RESTING-STATE FMRI IMAGES

    Oct 1, 2025, 00:00

  • RWD18 ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE AND ITS INFLUENCING FACTORS IN CHINESE PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY

    Oct 1, 2025, 00:00

  • RWD268 IMPACT OF MEDICAL INSURANCE PRICE NEGOTIATION POLICY ON INNOVATION OF CHINESE LISTED PHARMACEUTICAL COMPANIES: DIFFERENCE-IN-DIFFERENCES ANALYSIS

    Oct 1, 2025, 00:00

  • RWD281 LEVERAGING NATIONWIDE HEALTH AND INSURANCE RECORDS TO TRACK BIOLOGIC DRUG DIFFUSION IN IBD: A 20-YEAR REAL-WORLD STUDY FROM ISRAEL

    Oct 1, 2025, 00:00

  • RWD260 A COMPARATIVE ANALYSIS OF THE REDAPT SYSTEM IN REVISION TOTAL HIP ARTHROPLASTY: EVIDENCE FROM A LARGE US CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD77 HEALTHCARE UTILIZATION PATTERNS IN EARLY-STAGE BREAST CANCER TAIWANESE PATIENTS: A REAL WORLD EVIDENCE-BASED SUBTYPE-SPECIFIC STUDY

    Oct 1, 2025, 00:00

  • RWD146 ASSOCIATION BETWEEN FRAILTY STATUS AND GLYCEMIC CONTROL IN MIDDLE-AGED AND OLDER ADULTS WITH TYPE 2 DIABETES: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK COHORT

    Oct 1, 2025, 00:00

  • RWD62 TREATMENT PATTERNS FOR CHEMOTHERAPY-INDUCED ANEMIA IN CHINESE POPULATION: A MULTI-CENTER RETROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD103 CHARACTERISTICS AND APPLICATIONS OF BODY SIZE DATA IN JAPANESE CLAIMS DATABASES

    Oct 1, 2025, 00:00

  • RWD67 ASSOCIATIONS BETWEEN SLEEP DURATION AND LIFESTYLE BEHAVIORS AMONG ADOLESCENTS IN HONG KONG: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD237 EVALUATING THE HEALTH IMPACT AND COST-EFFECTIVENESS OF GENDER-NEUTRAL VACCINATION OF 9-VALENT HUMAN PAPILLOMAVIRUS VACCINE IN THE PHILIPPINES USING A DYNAMIC TRANSMISSION MODEL

    Oct 1, 2025, 00:00

  • RWD44 COMPARATIVE EFFICACY AND SAFETY OF SODIUM PICOSULFATE AND POLYETHYLENE GLYCOL IN CHINESE POPULATION: A META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD95 COST OF ILLNESS ANALYSIS OF SELF-INJECTION OF BIOLOGICS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD216 REAL-WORLD STUDY ON TREATMENT PATTERNS AND ECONOMIC BURDEN OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN CHINA

    Oct 1, 2025, 00:00

  • RWD270 ENHANCING CAUSAL DISCOVERY IN CHRONIC DISEASES: THE MAGIC FRAMEWORK USING MULTIPLE LLMS

    Oct 1, 2025, 00:00

  • RWD112 ECONOMIC EVALUATION OF SELUMETINIB FOR TREATING PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 INOPERABLE PLEXIFORM NEUROFIBROMAS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD236 THE HEALTH-RELATED QUALITY OF LIFE, RENAL DYSFUNCTION AND BLADDER STONE ODDS AMONG INDIVIDUALS WITH SPINAL CORD INJURY WITH DIFFERENT BLADDER EMPTYING METHODS SURVEYED ACROSS CHINA: AN EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD233 CHARACTERISTICS OF AUSTRALIAN PBAC SUBMISSIONS USING RWE

    Oct 1, 2025, 00:00

  • RWD70 IMPACT OF CHILD MALTREATMENT ON HEALTH-RELATED QUALITY OF LIFE: FINDINGS FROM THE AUSTRALIAN LONGITUDINAL STUDY ON WOMEN’S HEALTH

    Oct 1, 2025, 00:00

  • RWD246 CONSUMER PREFERENCES FOR ATTRIBUTES AMONG VOLUNTARY HEALTH INSURANCE PLANS: A SYSTEMATIC REVIEW

    Oct 1, 2025, 00:00

  • RWD61 CHARACTERISING THE LATENCY PERIOD OF SECONDARY PRIMARY MALIGNANCY AND LYMPHOMA ONSET FOLLOWING TISAGENLECLEUCEL (CAR-T CELL THERAPY): A REAL-WORLD DATA ANALYSIS

    Oct 1, 2025, 00:00

  • RWD254 BENEFIT OF IMMEDIATE INITIATION OF NIRMATRELVIR/RITONAVIR AGAINST LONG COVID: REAL-WORLD COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD98 GENOME-WIDE AND PHENOME-WIDE ANALYSES TO IDENTIFY HIGH-RISK PROFILES FOR TYPE 1 DIABETES

    Oct 1, 2025, 00:00

  • RWD79 SEX DIFFERENCES IN THE NATIONWIDE INCIDENCE OF NEURODEVELOPMENTAL DISORDERS AMONG CHILDREN IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD126 UNDERSTANDING REAL-WORLD CLINICAL AND ECONOMIC BURDEN OF DIFFERENT DEVICES STRATEGIES FOR THE ENDOVASCULAR TREATMENT OF SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN JAPAN: A REAL-WORLD CLAIMS DATA ANALYSIS PROTOCOL

    Oct 1, 2025, 00:00

  • RWD149 ECONOMIC IMPLICATIONS OF GENERIC POMALIDOMIDE ADOPTION IN THE MANAGEMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: A BUDGET IMPACT ANALYSIS AT THE JALISCO INSTITUTE OF CANCEROLOGY

    Oct 1, 2025, 00:00

  • RWD293 COST-EFFECTIVENESS OF DOSTARLIMAB FOR ADVANCED OR RECURRENT MSI-H/DMMR ENDOMETRIAL CANCER IN ANTI-PD1/PD-L1 NAïVE PATIENTS: A TAIWAN'S NATIONAL HEALTH INSURANCE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD116 DISPARITIES IN HEALTH OUTCOMES AND CARE AMONG ALK-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS: REAL-WORLD EVIDENCE OF SOCIAL DETERMINANTS OF HEALTH

    Oct 1, 2025, 00:00

  • RWD282 REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS IN JAPAN: A RETROSPECTIVE CLAIMS ANALYSIS

    Oct 1, 2025, 00:00

  • RWD308 DOES IMPROVED HOSPITAL MANAGEMENT ENHANCE HEALTHCARE EFFICIENCY? EVIDENCE FROM COUNTY-LEVEL HOSPITALS IN CHINA

    Oct 1, 2025, 00:00

  • RWD41 REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF FIRST-LINE THERAPIES OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD128 INCORPORATING REAL-WORLD DATA AND MATHEMATICAL MODELING TO ESTIMATE THE UNDIAGNOSED CHRONIC HEPATITIS B POPULATION

    Oct 1, 2025, 00:00

  • RWD314 UNDERSTANDING THE IMPACT OF PATIENT ACTIVATION LEVELS ON ALZHEIMER’S CAREGIVING IN CHINA

    Oct 1, 2025, 00:00

  • RWD102 ASSESSING THE COST-UTILITY OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE TREATMENT AND THE NEED FOR REAL-WORLD EVIDENCE: A SINGAPORE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD309 USING REAL WORLD DATA TO ESTIMATE COMPLICATION COSTS FOR A DIABETES COST-EFFECTIVENESS MODEL: AN AUSTRALIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD50 CAN EQ-5D-5L DISCRIMINATE THE CLINICAL SEVERITY OF ASTHMA?

    Oct 1, 2025, 00:00

  • RWD21 PHARMACEUTICAL APPROACHES TO ENHANCING RWE DATA COLLECTED IN NON-INTERVENTIONAL STUDIES

    Oct 1, 2025, 00:00

  • RWD267 HEALTH INSURANCE STRATEGIES TO IMPROVE HEALTH EQUITY AMONG PATIENTS WITH RARE DISEASES IN CHINA: A MICROSIMULATION-BASED STUDY

    Oct 1, 2025, 00:00

  • RWD277 COST-UTILITY IN DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION [DESTINY-HF]: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL-BASED ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD224 PREVALENCE AND ADVANCED SYSTEMIC TREATMENT PRESCRIPTION PATTERNS FOR SCALP PSORIASIS IN THE REAL-WORLD DERMATOLOGY SETTING IN THE UNITED STATES

    Oct 1, 2025, 00:00

  • RWD11 INTERVENTIONS PROMOTING THE ACCEPTANCE AND UPTAKE OF GENERIC MEDICINES: A SYSTEMATIC REVIEW

    Oct 1, 2025, 00:00

  • RWD206 SYSTEMATIC REVIEW AND QUALITY ASSESSMENT OF PHARMACOECONOMIC RESEARCH LITERATURE ON TRADITIONAL CHINESE MEDICINE

    Oct 1, 2025, 00:00

  • RWD305 IMPACT OF CAREGIVING ON THE DISEASE BURDEN AMONG PATIENTS WITH FEMALE-SPECIFIC CANCERS (BREAST, CERVICAL, OVARIAN, UTERINE) IN JAPAN

    Oct 1, 2025, 00:00

  • RWD271 SEQUENTIAL CDK4/6 INHIBITOR THERAPY VERSUS MTOR INHIBITOR THERAPY FOLLOWING INITIAL CDK4/6 INHIBITOR IN HR+/HER2- ADVANCED BREAST CANCER

    Oct 1, 2025, 00:00

  • Editorial Board

    Sep 5, 2025, 08:27

  • Lifetime Cost-Effectiveness of Using the Chinese Diabetes Risk Score for Prediabetes Screening in China

    Sep 1, 2025, 00:00

  • Impact of Improved Low-Density Lipoprotein Cholesterol Control in Patients with Diabetes in Malaysia: A Model-Based Population Health and Economic Analysis

    Sep 1, 2025, 00:00

  • Adaptation of the Experimental Version of EQ-5D-Y-5L Into Bahasa Indonesia

    Sep 1, 2025, 00:00

  • Cost-Effectiveness of an Enhanced Patient Care Intervention for Improving Viral Suppression Among Kenyan Adults Living With HIV

    Sep 1, 2025, 00:00

  • Cost-Utility and Budget Impact Analysis of Immunotherapy for First-Line Treatment of Advanced Kidney Cancer in Latin America: Evidence From Uruguay

    Sep 1, 2025, 00:00

  • Savings Through Telemedicine: Addressing Hidden Costs and Quality Concerns

    Sep 1, 2025, 00:00

  • Savings From Biosimilars Use in the Italian National Health Service

    Sep 1, 2025, 00:00

  • Validation of the Bangla Version of the HeartQoL Questionnaire for Patients With Coronary Heart Disease in Bangladesh

    Sep 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence

    Sep 1, 2025, 00:00

  • Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years in Singapore

    Sep 1, 2025, 00:00

  • Establishing the Groundwork for Future Research Into Adherence Measurement for Patients With HIV/AIDS

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • Evaluating the Cost-Effectiveness of Pharmacological Therapy in Alzheimer Disease in Brazil

    Sep 1, 2025, 00:00

  • Admissions and Deaths Due to Heart Failure and Acute Myocardial Infarction in the State of Minas Gerais: Analysis of Time Series

    Sep 1, 2025, 00:00

  • Epidemiology and Economic Burden of Suicide Among Brazilian Workers: Trends, Occupational Disparities, and Gender Differences

    Sep 1, 2025, 00:00

  • Validation and Cross-Cultural Adaptation of Treatment Satisfaction Questionnaire for Medication Version 2 Among Older Adult Patients in Malaysia: A Psychometric Testing Study

    Sep 1, 2025, 00:00

  • Breast Cancer Screening Using Clinical Breast Examination: A Cost-Effectiveness Analysis for South Africa

    Sep 1, 2025, 00:00

  • Table of Contents

    Sep 1, 2025, 00:00

  • The Quality of Economic Evaluations of Interventions to Improve Women and Child Health in Latin America: A Systematic Review

    Jul 17, 2025, 13:55

  • Cost-Effectiveness Analysis of Angiotensin Receptor Neprilysin Inhibitor Compared With Angiotensin-Converting Enzyme Inhibitor Among Patients With Heart Failure With Reduced Ejection Fraction in Malaysia

    Jul 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Prostate Specific Antigen Screening Among Chinese Men

    Jul 1, 2025, 00:00

  • Health-Related Quality of Life in Children With Sickle Cell Anemia in Malaria-Endemic Regions: The Impact of Disease States and Malaria Prevention Strategies

    Jul 1, 2025, 00:00

  • Mapping KDQOL-36 Onto EQ-5D-5L and SF-6Dv2 in Patients Undergoing Dialysis in China

    Jul 1, 2025, 00:00

  • Healthcare Costs of Myocardial Infarction in Denmark: A Nation-Wide Registry-Based Cohort Study

    Jul 1, 2025, 00:00

  • Disease and Economic Burden of COVID-19 in the Prevaccine Era in a Fragmented Health System: The Argentine Case

    Jul 1, 2025, 00:00

  • Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study

    Jul 1, 2025, 00:00

  • Cost-Effectiveness of the Kidney Transplant Compared With Hemodialysis in End-Stage Renal Disease in Dubai, the United Arab Emirates: A Cost-Utility Study

    Jul 1, 2025, 00:00

  • Table of Contents

    Jul 1, 2025, 00:00

  • Diabetes Mellitus in Colombia: Estimates of the Years of Life Lost

    Jul 1, 2025, 00:00

  • Author Reply

    Jul 1, 2025, 00:00

  • Making the Investment Case for Mental Health in Low- and Middle-Income Countries

    Jul 1, 2025, 00:00

  • Cost-Utility Analysis and Efficiency Frontier of Drugs Available in Brazil for the Treatment of Relapsing-Remitting Multiple Sclerosis

    Jul 1, 2025, 00:00

  • Cost-Utility and Budget Impact Analyses of Herpes Zoster Vaccines in Patients With Human Immunodeficiency Virus in Thailand

    Jul 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Mammography-Based Breast Cancer Screening in Indonesia

    Jul 1, 2025, 00:00

  • The Quality of Economic Evaluations of Interventions to Improve Women and Child Health in Latin America: A Systematic Review

    Jul 1, 2025, 00:00

  • Ethical and Statistical Issues in the Randomized Controlled Trial Assessing Cost-Effectiveness of Olanzapine Versus Aprepitant

    Jul 1, 2025, 00:00

  • Cost-Utility Analysis and Efficiency Frontier of Drugs Available in Brazil for the Treatment of Relapsing-Remitting Multiple Sclerosis

    Jul 1, 2025, 00:00

  • Editorial Board

    Jul 1, 2025, 00:00

  • Assessing Women’s Preference and Willingness to Pay for Breast Cancer Screening: A Discrete Choice Experiment Approach

    Jul 1, 2025, 00:00

  • Health-Related Quality of Life in Patients With Alzheimer Disease in Malaysia: Evidence From EQ-5D and QOL-AD

    Jul 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Inclisiran for the Treatment of Primary Hypercholesterolemia or Mixed Dyslipidemia in Singapore

    May 1, 2025, 00:00

  • Matching-Adjusted Indirect Comparison Studies in Oncology: A Scoping Review Focused on Reporting Quality

    May 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Pharmacological Treatment With Insulin and Insulin Analogs for Type 1 and Type 2 Diabetes Mellitus in Colombia

    May 1, 2025, 00:00

  • Quality of Life of Older Adults Living With Dementia and Caregiver Strain in Benin

    May 1, 2025, 00:00

  • Table of Contents

    May 1, 2025, 00:00

  • Patient-Reported Experience and Outcome Measures of Patients Living With Diabetes: Associations Among Different Factors

    May 1, 2025, 00:00

  • Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Adults in the Philippines

    May 1, 2025, 00:00

  • Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System

    May 1, 2025, 00:00

  • Toward Better Measurement of Financial Risk Protection in Health Expenditure: The Case of Chile

    May 1, 2025, 00:00

  • Life With Cystic Fibrosis: The Socioeconomic Impact on Patients and Their Caregivers

    May 1, 2025, 00:00

  • Estimation of the Effects and Costs of Lifestyle Intervention and Treatment With Voglibose in the Japanese Prediabetic Population: A Cost-Effectiveness Analysis

    May 1, 2025, 00:00

  • Economic and Disease Burden of Multiple Sclerosis in Colombia

    May 1, 2025, 00:00

  • Valuing an Index of Sanitation-Related Quality of Life in Urban Mozambique: A Discrete Choice Experiment

    May 1, 2025, 00:00

  • Cost Analysis of Epilepsy Healthcare in Adults: A Direct Cost Estimate From a Colombian Perspective

    May 1, 2025, 00:00

  • Comparing the Measurement Properties of the Preliminary Version of the EuroQol Health and Well-Being and EQ-5D-5L in Patients, Healthy General Public, and Caregivers

    May 1, 2025, 00:00

  • Editorial Board

    May 1, 2025, 00:00

  • Reviewer Acknowledgment

    Apr 30, 2025, 10:29

  • Table of Contents

    Mar 17, 2025, 11:40

  • Cost-Utility Analysis of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy Regimen in Comparison With Gemcitabine and Cisplatin Chemotherapy Regimen in the Treatment of Patients With Muscle Invasive Bladder Cance ...

    Mar 1, 2025, 00:00

  • Understanding What Matters: Stakeholder Views on Decision Criteria for Cancer Drug Selection in the Public Sector in Malaysia

    Mar 1, 2025, 00:00

  • Editorial Board

    Mar 1, 2025, 00:00

  • Budget Impact Analysis of Intravitreal Injections Used to Treat Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in the Dubai Healthcare System

    Mar 1, 2025, 00:00

  • Glycemic and Blood Pressure Control in Type 2 Diabetes Mellitus: Disability Costs Covered by Social Security, Evidence From Mexico

    Mar 1, 2025, 00:00

  • Health-Related Quality of Life in a Slovak Representative Sample: A Validation Study of the Short Form-8 Scale

    Mar 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Idursulfase for the Long-Term Treatment of Hunter Syndrome Using a Partitioned-Survival Model Approach in R

    Mar 1, 2025, 00:00

  • Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece

    Mar 1, 2025, 00:00

  • The High Cost of the Legal Route in Public Health: The Impact of the Judicialization of Medicines in the Municipal Unified Health System in Campinas

    Mar 1, 2025, 00:00

  • Rare Oncological Diseases and Their Large Slice in Demands to the Brazilian Government for Health Technologies Over 12 Years Since the Creation of CONITEC

    Mar 1, 2025, 00:00

  • Healthcare Costs and Early Complications in Liver-Transplanted Patients With Portal Vein Thrombosis: Experience From a Colombian Reference Center

    Mar 1, 2025, 00:00

  • Cost-Effectiveness of Aerial Logistics for Immunization: A Model-Based Evaluation of Centralized Storage and Drone Delivery of Vaccines in Ghana Using Empirical Data

    Mar 1, 2025, 00:00

  • Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology Setting

    Mar 1, 2025, 00:00

  • Utility Values of Health Status in Gastric Cancer: A Systematic Review

    Mar 1, 2025, 00:00

  • Efficiency Analysis of Healthcare Systems in Latin American and Caribbean Countries: An Application Based on Data Envelopment Analysis

    Mar 1, 2025, 00:00

  • Exploring the Potential Health and Economic Benefits of Optimized Low-Density Lipoprotein Cholesterol Management in Malaysia’s Atherosclerotic Cardiovascular Disease Population: A Model-Based Analysis

    Mar 1, 2025, 00:00

  • Using Real-World Evidence for Health Technology Assessment in Asia: Suggested Typology and Scoping Review

    Mar 1, 2025, 00:00

  • The Burden of Alzheimer’s Disease and Its Costs to a Healthcare System in a Large Population in Brazil

    Jan 1, 2025, 00:00

  • Postpartum Screening for Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus: A Cost-Effectiveness Analysis in Singapore

    Jan 1, 2025, 00:00

  • Table of Contents

    Jan 1, 2025, 00:00

  • Health Services Costs of Clinical Heart Failure With Reduced Ejection Fraction in Singapore

    Jan 1, 2025, 00:00

  • Psychometric Evaluation of the Bengali Short Form 12 Version 2 Health Survey in Patients With Inflammatory Bowel Disease

    Jan 1, 2025, 00:00

  • Editorial Board

    Jan 1, 2025, 00:00

  • Main Predictors of Decreasing in Quality of Life in Patients With Post-COVID-19: A Cross-Sectional Study

    Jan 1, 2025, 00:00

  • The Use of a Specialized Oral Nutritional Supplement in the Management of Chronic Wounds in Patients With and Without Diabetes Mellitus: Cost-Effectiveness Analysis

    Jan 1, 2025, 00:00

  • Economic Burden of Sickle Cell Disease in Saudi Arabia

    Jan 1, 2025, 00:00

  • Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment

    Jan 1, 2025, 00:00

  • Chronic Pain—A Global Problem Demanding Local Evidence and Guidelines

    Jan 1, 2025, 00:00

  • Population Norms and Disutility Catalog for Chronic Conditions in Sri Lanka

    Jan 1, 2025, 00:00

  • Savings Through Telemedicine: Initial Data From a Hospital-at-Home Program

    Jan 1, 2025, 00:00

  • An EQ-5D-5L Value Set for Ghana Using an Adapted EuroQol Valuation Technology Protocol

    Jan 1, 2025, 00:00

  • The Reform Dynamics of State Management Practices in the Healthcare Sector of the Republic of Kazakhstan: A Global and Local Perspective

    Jan 1, 2025, 00:00

  • Editorial Board

    Nov 1, 2024, 08:25

  • Analysis of Factors Influencing Hospitalization Expenses of Patients With Gastric Cancer in Shanghai, 2014-2021: Based on Grey Relational Analysis and Structural Equation Modeling [Editor's Choice]

    Nov 1, 2024, 00:00

  • Custo Direto do Tratamento do Acidente Vascular Cerebral Isquêmico na Perspectiva de um Hospital Público Terciário (Direct Cost of Treating Ischemic Stroke From the Perspective of a Tertiary Public Hospital)

    Nov 1, 2024, 00:00

  • Psychometric Measurements of the Adherence to Refills and Medication Scales Among Patients With HIV/AIDS in Indonesia

    Nov 1, 2024, 00:00

  • Patient Experience of Herpes Zoster Disease in Argentina: Validation of a Health-Related Quality of Life Conceptual Model

    Nov 1, 2024, 00:00

  • Cost-effectiveness of the Recombinant Zoster Vaccine Among People Living with Human Immunodeficiency Virus in Japan [VHRI Volume 44, November 2024, 101025]

    Nov 1, 2024, 00:00

  • Changes in Health Spending During the COVID-19 Pandemic by Expenditure Type and Household Profiles in Mexican Households [Editor's Choice]

    Nov 1, 2024, 00:00

  • Health-Related Quality of Life and Economic Analysis of Olanzapine Versus Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Malaysia

    Nov 1, 2024, 00:00

  • The 30-Billion-Dollar Distribution Markups and Taxes of Pharmaceuticals in Latin American Countries: Impact, Options, and Trade-Offs [Editor's Choice]

    Nov 1, 2024, 00:00

  • Societal Preferences in Health Technology Assessments for Rare Diseases and Orphan Drugs: A Systematic Literature Review of New Analytic Approaches

    Nov 1, 2024, 00:00

  • Cost-Effectiveness of Dolutegravir Compared With Efavirenz for Prevention of Perinatal Transmission in Women Presenting With HIV in Late Pregnancy in Uganda

    Nov 1, 2024, 00:00

  • Health-Related Quality of Life in Chronic Pain Treated With Tapentadol Versus Oxycodone/Naloxone and Its Determinants: A Real-World, Single-Center Retrospective Cohort Study in Spain

    Nov 1, 2024, 00:00

  • Custo-Efetividade de Diferentes Tratamentos Minimamente Invasivos Para Disfunção Temporomandibular de Origem Articular sob a Perspectiva do Sistema Público de Saúde Brasileiro

    Nov 1, 2024, 00:00

  • Table of Contents

    Nov 1, 2024, 00:00

  • Assessing the Impact of a Designated Pharmacist Intervention on Drug Treatment Costs and Technical Efficiency in the Hemato-Oncology Outpatient Clinic [Editor's Choice]

    Nov 1, 2024, 00:00

  • Treatment Cost and Psychological Impact of Burkitt Lymphoma on Ghanaian Families and Caregivers

    Nov 1, 2024, 00:00

  • Retraction notice to Cost-effectiveness of the Recombinant Zoster Vaccine among People Living with Human Immunodeficiency Virus in Japan

    Nov 1, 2024, 00:00

  • Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3

    Nov 1, 2024, 00:00

  • Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates

    Sep 1, 2024, 00:00

  • Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran [Editor's Choice]

    Sep 1, 2024, 00:00

  • Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study

    Sep 1, 2024, 00:00

  • Societal Preferences for Subsidizing Treatments Targeting Patients With Advanced Illness: A Discrete Choice Experiment [Editor's Choice]

    Sep 1, 2024, 00:00

  • Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database

    Sep 1, 2024, 00:00

  • Patient Preferences for Out-of-Hospital Cardiac Arrest Care in South Africa: A Discrete Choice Experiment

    Sep 1, 2024, 00:00
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »